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Individuals with schizophrenia have abnormal EEG-based measures of brain activity to auditory 
stimuli. However, it is not known whether the deficits are purely sensory in nature or reflect the 
inability of executive control cognitive centers to modulate sensory processing by selective 
attention, another cognitive function impaired in schizophrenia. To address this issue, the late 
perceptual N100 event-related auditory brain potential was examined between attend and ignore 
conditions. The N100 is increased in healthy individuals when sounds are attended, providing an 
objective measure of selective attention effects. Eighteen individuals experiencing their first 
psychotic episode within the schizophrenia-spectrum (FE) and 17 matched healthy controls (HC) 
were compared on two auditory attention tasks. In the single tone task, participants ignored the 
tones in one block and pressed a button to every 7th tone in another block. In the two-tone 
“oddball” task, participants ignored tones in one block and pressed to the oddball tone 
(infrequent higher frequency tone) in another. FE showed marginally smaller N100 across tasks 
and conditions (p=0.053). Attentional modulation of the N100 was marginally impaired in FE 
(Group x Attention, p =0.058). The increase in N100 was greater for the oddball task (p =0.04) 
and follow up analyses revealed that FE did not modulate N100 during the oddball task with 
attention to the same extent as HC (p = 0.051).  This deficit may reflect a long-range functional 
disconnection between cognitive control cortical areas and sensory cortex early in disease 
course. This difference in N100 modulation between groups may be useful in learning more 
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about the neurophysiology of the disease and could be utilized as a potential biomarker for 
diagnosis among clinically high-risk individuals.  
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1.0  INTRODUCTION 
Schizophrenia is a chronic psychiatric disorder that results in severe social, behavioral, and 
cognitive impairment. It was originally considered a dementing disorder in the late 19th century, 
called dementia praecox, hypothesized to reflect a neurodegenerative disease based on the 
pervasive deficits for most individuals (Kraepelin 1902). The disease was soon renamed 
schizophrenia, meaning “split mind,” based on the cognitive and affective symptoms in disease 
presentation rather than a possible biological cause, as dispute arose whether the disease had an 
invariably dementing course (Bleuler 1911). Worldwide, lifetime prevalence of schizophrenia is 
believed to be around 1%, with a slightly higher rate of incidence in men compared to women 
(McGrath 2004). Within the age group of 15-44 years old, schizophrenia is listed as number 
eight in the leading causes of disability-adjusted life years (DALY), often thought of as lost years 
of “healthy” life (Rössler 2005). In 2013, this significant economic burden cost the United States 
over $155.7 billion, with $117.3 billion in indirect costs (Cloutier et al 2016). 
Earlier clinical intervention may help ease this burden, with studies showing that early 
treatment can decrease the long-term morbidity of schizophrenia (Wyatt et al 1998). However, 
schizophrenia and other major psychotic disorders lack the clear-cut biomarkers that aid in 
identification before psychosis emerges (Kapur 2012). Although there have been great strides in 
the pathology-based research of schizophrenia, the underlying mechanisms are still poorly 
understood, making the establishment of routine biomarkers difficult. Overcoming this obstacle 
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through biomarker design could lead to improved diagnostic decision-making, better 
identification of high risk individuals, and more effective prodromal treatments. 
This study focused on individuals in the first episode schizophrenia spectrum, defined as 
being within their first psychotic episode and on antipsychotic medication for less than 2 months. 
Untreated psychosis has been linked to more severe psychopathological symptoms due the 
natural course of the disease (Cechnicki et al 2014), so timely intervention is important. 
Preventing the emergence of psychosis would be ideal. Having the ability to predict the 
development of psychosis and initiating prophylactic treatment would provide these individuals a 
higher quality of life.  
The hunt for biomarkers of incipient psychosis has been an active area of research, with 
projects that investigate proteomic indicators in the blood, neuroimaging markers, cognitive test 
abnormalities, pharmacodynamic activity, and electroencephalogram (EEG) measures (Morgan 
et al 2012, Perez et al 2014, Schwarz et al 2012). Mismatch negativity (MMN) has been favored 
as a potential biomarker in EEG data. The MMN response describes an event related potential 
(ERP), or time-locked electrophysiological response to a stimulus, that occurs during auditory 
tasks. The passive task that elicits this response is a deviant tone presented at a lower probability 
among other tones. The rare sound causes an auditory processing response in the form of a 
negative deflection around 100-250 ms after the onset of the deviant stimulus (Sams et al 1985). 
Individuals with schizophrenia for many years show decreased amplitude of their MMN 
response when compared to healthy controls (Javitt et al 1998). However, when MMN was 
studied in young schizophrenia patients recently diagnosed, the marked reductions in amplitude 
seen in chronic patients were not present (Salisbury et al 2002, 2007, 2017). Since the MMN 
deficit was not present early in the disease course, this ERP is not a convincing biomarker for 
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diagnosis. For example, one leading group initially reported reduced MMN in individuals that 
transitioned to psychosis among a clinical high risk for psychosis group (CHR, Atkinson et al 
2012), suggesting MMN might be a biomarker for incipient psychosis. However, the same group 
recently failed to replicate that finding, showing larger MMN in transitioners among CHR 
individuals, concluding that MMN was not a viable biomarker for the psychosis prodrome 
(Atkins et al 2017).  
Still, other candidate neurophysiological markers may be developed to provide objective 
and economical biomarkers of disease presence. Selective attention, the ability to focus on one 
percept among other competing sensations, has long been understood as a fundamental cognitive 
deficit in psychosis (Everett et al 1989).  This symptom is often present in the prodromal phase 
of schizophrenia disease progression, making it a promising target for a potential biomarker 
(Cornblatt & Erlenmeyer-Kimling 1985, Mohamed et al 1999). Auditory processing deficits are 
also reflected in many of the symptoms of schizophrenia, such as verbal hallucinations and 
impaired auditory perception (Turetsky et al 2009). The study of these attentional and auditory 
processing deficits can be joined when examining an auditory ERP called the N100 response.  
The N100 response is a negative deflection that occurs approximately 100 ms after the 
onset of a stimulus. The amplitude of the N100 waveform is enhanced when a subject is paying 
attention to a stimulus that is task-relevant, such as demonstrated in the oddball paradigm 
(Hillyard et al 1973). This paradigm involves the presentation of rare deviant stimuli among 
standard stimuli. Individuals with long-term schizophrenia seem to lack the attentional 
modulation of the N100 response that is seen in healthy subjects (reviewed in Rosburg et al 
2008). If present in first episode schizophrenia-spectrum individuals, this brainwave abnormality 
could serve as an objective measure of system-level selective attention circuit pathophysiology 
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that could also be utilized as a biomarker of disease presence. A deficit in the size of the N100 
was observed during the oddball paradigm in newly hospitalized schizophrenia patients 
(Salisbury et al 2010), but it is unknown if this deficit was the result of a sensory component of 
the response or an attentional component. Keeping in mind the failure of MMN to be reduced at 
first episode despite great impairment in long-term illness, it is important to replicate the N100 
reduction in first episode schizophrenia to assess its viability as a potential biomarker of incipient 
psychosis (i.e. even earlier in the disease course). Further, understanding whether the observed 
N100 reduction (Salisbury et al 2010) reflects a simple sensory deficit or an essentially cognitive 
deficit will aid in the design of appropriate tasks to be tested as biomarkers.  
This study examined the N100 and its attentional modulation in first episode 
schizophrenia-spectrum subjects and matched healthy control individuals. A one-tone task and a 
two-tone oddball tone task were performed by the subjects while paying attention to the stimuli 
and while ignoring. The attend condition was expected to enhance the N100 response amplitude 
in both tasks relative to the ignore condition. A deficit in first episode individuals in the ignore 
condition would reflect a more purely sensory abnormality. A deficit in the enhancement of 
N100 with attention in first episode individuals would indicate a more cognitive system-level 
impairment. Either outcome would reveal an auditory processing abnormality in schizophrenia 
that is present at first break, and the abnormal waveform could be tested as a potential biomarker 
for disease presence prior to psychosis.  
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2.0  METHODS 
2.1 PARTICIPANTS 
Eighteen first episode schizophrenia spectrum individuals (FE) recruited from consecutive 
admissions to Western Psychiatric Institute and Clinic (WPIC) inpatient and outpatient services 
were compared with 17 matched healthy controls (HC). Within the FE group, 13 were diagnosed 
with schizophrenia (paranoid =10, undifferentiated =3), 3 with schizoaffective disorder 
(depressed type =2, bipolar type =1), and 2 with psychotic disorder not otherwise specified 
(NOS). FE participated within their first episode of psychosis and had less than two months of 
lifetime antipsychotic medication exposure (medicated =12, unmedicated =4, unknown =2).  
All subjects had normal hearing as assessed by audiometry, at least nine years of 
schooling, and an estimated IQ over 75. None of the subjects had a history of concussion or head 
injury with sequelae, history of alcohol or drug addiction, detox in the last five years, or 
neurological comorbidity. Groups were matched for age, gender, premorbid estimates of 
intelligence based on the Wechsler Abbreviated Scale of Intelligence (WASI) IQ, and parental 
socioeconomic status. The 4-factor Hollingshead Scale was used to measure socioeconomic 
status (SES) in participants and in their parents. Demographic information can be found in Table 
1. All participants provided informed consent and were paid for participation. All procedures 
were approved by the University of Pittsburgh IRB.  
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Table 1. Subject Demographics. The demographic averages for both groups are included along with the results of 
statistical analyses. Chi-squared tests were used to compare gender and t-tests were used to compare age, IQ, PSES, 
and SES.  
 FE HC Statistics 
Number 18 17  
Gender 14M / 4F 12M / 5F x2 =0.24, p =0.63 
Age 22.06 ± 4.66 21.59 ± 4.90 t(33) =0.29, p =0.78 
WASI IQ 106.72 ± 13.99    110.94 ± 9.74    t(33) =-1.04, p =0.31 
PSES 43.68 ± 13.09 50.79 ± 13.95 t(32) =-1.53, p =0.14 
SES 27.06 ± 11.55 32.91 ± 15.19 t(33) =-1.28, p =0.21 
MATRICS 37.06 ± 15.00 49.83 ± 5.71 t(33) =-3.36, p =0.003 
 
2.2 DIAGNOSTIC ASSESSMENTS 
Diagnosis was based on the Structured Clinical Interview for DSM-IV (SCID-P). Symptoms 
were rated using the Positive and Negative Symptom Scale (PANSS), Scale for Assessment of 
Positive Symptoms (SAPS), and Scale for Assessment of Negative Symptoms (SANS). All tests 
were conducted by an expert diagnostician. 
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2.3 NEUROPSYCHOLOGICAL TESTS 
All participants completed the MATRICS Cognitive Consensus Battery and the WASI. Social 
functioning was assessed with the Global Assessment Scale (GAS), Global Functioning: Social 
and Role scales (GF:S, GF:R), the brief UCSD Performance-based Skills Assessment (UPSA-B) 
and the Social Functioning Scales (SFS).   
2.4 PROCEDURE 
EEG was collected while participants partook in two different auditory tasks. Stimuli were 
generated with Tone Generator (NCH Software), and presented in Presentation (Neurobehavioral 
Systems, Inc.).  Binaural auditory stimuli were presented at 80 dB using Etymotic 3A insert 
earphones, with loudness confirmed with a sound meter. Participants watched a silent nature 
video while tones were played over earphones. 
2.5 STIMULI 
2.5.1 Auditory Evoked Potential (AEP) Task 
Stimuli consisted of repetitious tones (1kHz, 50 ms duration, 5 ms rise/fall) presented with a 
stimulus onset asynchrony of 1050-1550 ms. A total of 340 tones were presented. Following 
each tone, a 500 ms duration 40Hz click train was inserted in the inter-tone interval, but the 
results of this gamma oscillation investigation will not be further discussed in this paper. In one 
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block, participants were asked to ignore the tones and focus on a silent nature video. In another, 
participants were asked to pay attention to the tones and press a button to every seventh tone. 
Blocks were counterbalanced. 
2.5.2 Oddball Tone Task 
Stimuli consisted of a standard tone (1000 Hz, 50 ms duration, 5 ms rise/fall) and a deviant tone 
(1200 Hz, 50 ms duration, 5 ms rise/fall) presented with a stimulus onset asynchrony of 1050-
1550 ms. A total of 400 tones were presented, including 340 standard tones (85%) and 60 
deviant tones (15%). As for the AEP task, a 500 ms duration 40Hz click train was inserted in the 
inter-tone interval, but the results of attention of the gammaband oscillation investigation will not 
be further discussed here. In one block participants were asked to ignore the tones and focus on a 
silent nature video. In another, participants were asked to pay attention to the tones and press a 
button to every deviant tone. Blocks were counterbalanced. 
2.6 EEG RECORDING 
EEG was recorded using a low impedance 60-electrode EEG array based on the 10-10 system. It 
was part of an MEG Elekta Neuromag system with a sampling rate of 1000 Hz and an online 
bandpass filter of 0.1 – 330 Hz. EEG recordings were referenced to the left mastoid and the right 
mastoid was used as ground. Additional bipolar leads placed above and below the left eye 
(VEOG) as well as lateral to the outer canthi of both eyes (HEOG) were used to monitor blinks 
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and horizontal eye movements. Bipolar ECG leads were placed just below the left and right 
clavicle. 
2.7 EEG SIGNAL PREPROCESSING 
Pre-processing was done off-line with the MATLAB-based EEGLAB Toolbox (Delorme and 
Makeig, 2004). EEG was filtered at 0.5 Hz to remove DC drifts and skin potentials. Data were 
visually examined and any channels with excessive noise were interpolated. ICA was then 
performed to detect and remove eye-blink, eye movement, and ECG components in the EEG 
data.   
2.8 EEG ANALYSIS 
Following pre-processing in EEGLAB, event-related potentials were processed using 
BrainVision Analyzer2 (Brain Products GMBH). ICA-corrected EEG data were rereferenced to 
the averaged mastoids and low-pass filtered at 20 Hz to remove muscle and other high frequency 
artifact. EEG data were then segmented into epochs starting 100ms prior to the stimulus and 
ending 1000ms after. These epochs were baseline-corrected using the 100ms pre-stimulus 
baseline and epochs in which the voltage exceeded ±50 µV in EEG channels were rejected.  
Averages were constructed for the standard tones in the AEP task and oddball task. The 
N100 response was measured by detection of the peak amplitude between 75 ms and 125 ms at 
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Fz, where enhancement of the N1 was largest, in each participant, and a 10ms segment centered 
around this peak was exported.  
2.9 ANALYSES 
Group demographics and neuropsychological scores were compared using t-tests and chi-squared 
tests where appropriate. N100 analyses utilized repeated-measures ANOVA with group (FE, 
HC) as the between subjects factor and task (AEP or oddball) and attention condition (attend or 
ignore) as within subjects factors. Follow-up task analyses utilized repeated-measures ANOVA 
with group (FE, HC) as the between subjects factor and attention condition (attend or ignore) as 
the within subjects factor. Subsequent comparisons of specific conditions and tasks between 
groups utilized t-tests. N100 enhancement was calculated by subtracting the ignore condition 
N100 voltage from the attend condition N100 voltage for each task. Spearman’s correlations 
were performed between N100 enhancement and neuropsychological, clinical, and social 
functioning variables for FE participants. Values are reported as Mean ± SD. Significance was 
attained at p <0.05.   
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3.0  RESULTS 
ERP Waveforms across tasks and conditions are presented in Figure 1. An omnibus ANOVA 
revealed marginally significant reductions of N100 in FE across tasks and conditions (F(1,33) 
=4.03, p =0.053). The AEP task N100 responses were significantly smaller than those of the 
oddball task (F(1,33) =10.646, p =0.003). This effect did not interact between groups. N100 was 
larger across tasks in the attend condition compared to the ignore condition (F(1,33) =19.725, p 
<0.001). Of primary importance, however, the effect of attention on N100 was marginally 
greater in HC than in FE (F(1,33) =3.865, p =0.058). Finally, there was an interaction between 
task and attention such that the effect of attention on N100 response was significantly greater in 
the oddball task than in the AEP task (F(1,33) =4.512, p =0.041). To follow up on this 
interaction, separate ANOVAs were conducted for each task. Statistical means can be found in 
Table 2. 
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Figure 1. Event Related Potential Averages. Waveforms for FE and HC groups collected at electrode position Fz. 
1a) Attend (black) and ignore (red) ERP events in healthy controls for the AEP task. 1b) Attend and ignore ERP 
events in first episode schizophrenia participants for the AEP task. 1c) Attend and ignore ERP events in healthy 
controls for the oddball task. 1d) Attend and ignore ERP events in the first episode schizophrenia participants for the 
oddball task. Arrows indicate N100 responses. 
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3.1 AEP TASK 
The N100 amplitude in the FE group was not significantly different from the HC group on the 
AEP task. There was trend-level significance in the effect of attention for this task, with the 
responses while attending showing larger amplitudes than responses while ignoring (F(1,33) 
=3.375, p =0.075). This effect of attention did not interact between groups (F(1,33) =1.018, 
p=0.320). 
3.2 ODDBALL TASK 
The N100 amplitude in the FE group was significantly smaller than the HC (F(1,33) =5.665, p 
=0.023) to frequent tones on the two-tone oddball task. N100 responses were significantly larger 
when paying attention compared to ignoring the stimuli (F(1,33) =12.546, p <0.001). However, 
the effect of attention on N100 response was marginally larger in HC than FE (F(1,33) =4.093, p 
=0.051). Separate analyses of attend and ignore N100 in FE revealed a marginal effect of 
attention (p =0.055), while HC showed a marked effect (p <0.001). As can be observed in Table 
2, the effect of attention on N100 in this task was over two times greater in HC than FE. 
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Table 2. Mean N100 Responses. Calculated mean responses at Fz site used in statistical tests.  
  Mean (µV) Standard Deviation 
Group FE -1.20 1.43 
HC -2.02 1.32 
Task AEP -1.40 1.41 
Oddball    -1.82 1.35 
Group*Task FE AEP -1.08 1.48 
FE Oddball -1.31 1.39 
HC AEP -1.72 1.34 
HC Oddball -2.33 1.30 
Attention Attend -1.91 1.46 
Ignore -1.31 1.29 
Group*Attention FE Attend -1.36 1.51 
FE Ignore -1.03 1.35 
HC Attend -2.46 1.41 
HC Ignore -1.59 1.24 
Group*Attention*Task FE AT AEP -1.16 1.53 
FE AT Oddball -1.57 1.50 
FE IG AEP -0.99 1.42 
FE IG Oddball -1.06 1.28 
HC AT AEP -1.99 1.44 
HC AT Oddball -2.92 1.38 
HC IG AEP -1.45 1.24 
HC IG Oddball -1.73 1.23 
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3.3 N100 ENHANCEMENT CORRELATIONS WITH CLINICAL DATA IN 
ODDBALL TASK 
In FE, N100 enhancement on the oddball task was correlated with neuropsychological, clinical, 
and social functioning measures. (Recall, the oddball but not the AEP task was associated with 
N100 enhancement deficits in FE). Although not significant, estimates of premorbid functioning 
based on WASI IQ, tests selected to be resistant to the effects of psychosis, suggested higher 
premorbid IQ was reflected in a larger N100 enhancement.  N100 enhancement was associated 
with better MATRICS Overall Composite scores (ρ =-0.488, p =0.040), tests selected to be 
sensitive to the effects of psychosis on cognition. Higher scores on the negative symptom 
assessments were correlated with smaller N100 enhancement, utilizing the PANNS Negative 
factor scores (ρ =0.571, p =0.021) and the SANS scores (ρ =0.701, p =.001). Correlations were 
observed between role and social functioning and attentional modulation, indicating that poorer 
role and social functioning both currently and in the past year were associated with impaired 
ability to modulate N100 with attention. Correlation data can be found in Figure 2.  
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Figure 2. N100 Enhancement and Clinical Data from FE. Results from Spearman’s correlation tests for first 
episode schizophrenia spectrum. 2a) Intelligence measures through the Wechsler Abbreviated Scale of Intelligence 
and the MATRICS Consensus Cognitive Battery. 2b) Measurements of negative symptoms through Positive and 
Negative Syndrome Scale (PANSS) negative scale portion and the Scale for the Assessment of Negative Symptoms 
(SANS). 2c) Assessment of role functioning through the Global Functioning: Role Scales (GF:R) 2d) Assessment of 
social functioning through the Global Functioning: Social Scales (GF:S). 
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4.0  DISCUSSION  
The enhancement of the N100 response with attention in healthy controls matches results found 
in previous ERP studies and helps validate the tasks and procedure used in this study (Hillyard et 
al 1973). A deficit in this attentional enhancement of the N100 response has been shown in 
chronic schizophrenia (Rosburg et al 2008), but our results indicate that it is also impaired in first 
episode individuals, at least for the oddball task where attention seemed to have a larger effect. 
The auditory processing events modulated by selective attention that are reflected in the N100 
response appear to be abnormal even around the time of an individual’s first break. 
After analyzing waveform responses for subjects in both tasks independently, it was 
determined that the oddball task was more effective at demonstrating the deficit in attentional 
modulation in FE. We speculate that this is due to increased signal representation in perception 
that may occur on the more complex two-tone task. Follow-up paired t-tests revealed that the 
AEP task produced only trend-level attentional modulation, while the oddball task elicited robust 
modulation. It is possible that a single tone task is too simple for perceptual mechanisms, and 
only with increasing task complexity (as in going to two tone task) does sensory enhancement 
become necessary. Current work is examining this possibility by measuring increases in N100 
enhancement from 1 to 2 to 4 tone tasks.  
Another important finding is that when ignoring, the groups do not have significantly 
different N100 response amplitudes in either the AEP task (p =0.322) or the oddball task (p 
 19 
=0.121), shown in Figure 1 in red. This indicates that first episode schizophrenia-spectrum 
individuals have largely intact sensory processing, at least as reflected in the late perceptual 
N100. A difference between the two groups becomes apparent when adding an attention factor to 
the task. The dysfunction in N100 response does not seem to be linked exclusively to auditory 
processing centers in the auditory cortex. It may instead involve communication to the auditory 
cortex from other brain areas, such as the frontal and parietal lobes that support the executive 
attentional mechanisms (Petersen & Posner 2012).  
Our results suggest a long-range functional disconnection between cognitive control cortical 
areas and the auditory temporal lobes early in disease course. Further examination of this 
connection could lead to a better understanding of the attentional circuitry involved in auditory 
neurophysiology in schizophrenia. More specifically, this project’s focus on young patients 
provides information on the timing of disease progress, allowing researchers to learn more about 
which areas of functioning deteriorate first. A future direction of this project is to use 
concurrently recorded EEG and magnetoencephalogram (MEG) data along with structural MRI 
images to create a more complete picture of the underlying brain circuitry associated with these 
auditory responses. The combination of MEG and EEG data will reveal brain activity occurring 
not only at the scalp level, but also at the source level, as we use information from the 
electromagnetic fields to project activity on to the cortical surface (Huotilainen et al 1998). 
Structural MRI taken from each participant will allow for more accurate mapping of source 
activity within each individual’s head due to the personalized headspace. This allows us to 
investigate cortical dynamics of activity in the executive control and auditory nodes of the brain, 
and to investigate the inter-relationships between nodes.  
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 Correlations in N100 enhancement of FE during the oddball task were also analyzed. 
There was no significant correlation between modulation of N100 and premorbid intelligence as 
estimated by the WASI, although the direction of the association suggested better modulation 
with higher premorbid IQ. However, larger attentional modulation was associated with higher 
scores on the MATRICS Overall Composite score. Since the MATRICS battery was designed to 
include tests sensitive to the effects of psychosis on cognition, and is often utilized to track 
changes in cognitive function during an individual’s treatment for psychiatric disorders, it 
follows that our FE group would show significantly lower scores on this assessment than HC 
despite being matched for premorbid IQ. The correlation between lower cognitive functioning 
and impaired ability to modulate the size of the N100 ERP indicates that attentional enhancement 
is sensitive to the consequences of psychosis. Given that neuropsychological deficits predate 
overt psychosis (Woodberry et al 2008), this finding suggests failure of N100 enhancement on 
the oddball task is a candidate pre-psychosis biomarker. The significant association between 
negative symptoms and impaired attentional modulation suggests that these may be related to 
similar pathological prefrontal cortex systems. For example, Asami et al (2012) showed 
persistent negative symptoms were associated with longitudinal reductions of inferior frontal 
gyrus gray matter in first episode individuals, and the executive control system. Correlations that 
examined the relationship between N100 enhancement and social functioning showed that 
reduced modulation of N100 response was also slightly predictive of current and pre-psychosis 
levels of social role and functioning. This association suggests the current lack of N100 
enhancement is related to the degree of prodromal deficit.  
From a clinical perspective, the results of this study support reduction of attentional 
modulation of the N100 response as a promising biomarker for the development of a diagnostic 
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tool for clinically high-risk individuals. This group would include individuals that have family 
members with schizophrenia or are exhibiting abnormal behavior, such as reduced psychosocial 
functioning or mild psychotic symptoms (Fusar-Poli et al 2013). These individuals are generally 
believed to be in the prodromal phase of the disease, but the criteria for this group only results in 
a maximum of 4 in 10 individuals receiving a schizophrenia diagnosis (Yung et al 2004), and is 
likely to be closer to 2 in 10 (Nelson et al 2013). This low rate of conversion makes it difficult to 
predict individuals that would benefit from early treatment and often prevents clinicians from 
intervening before the first episode.  
 A possible next step for this study would be to bring the oddball task to the 
clinical high-risk group and determine if their N100 modulation is impaired like the first episode 
individuals, or if it more closely matches the modulation of healthy controls. Collecting data on 
conversion rates and ability to modulate the N100 response would test the effectiveness of this 
biomarker as a predictor of disease onset. Successful testing in this group could lead to improved 
prodromal treatments that help with the transition phase and even mitigate symptoms before they 
reach a critical level (McGorry et al 2002, Morrison et al 2004). The simple oddball task utilized 
in this study would be a relatively easy and inexpensive procedure and has the potential to 
improve the predictive power of conversion to a schizophrenia diagnosis.  
 We focused on the enhancement of N100 specifically, based on our group’s 
previous demonstration of a narrow temporal window of N100 enhancement with attention 
(O’Donnell et al 1995). However, inspection of Figure 1 indicates a broader negativity spanning 
the N100, P200, and N200 time windows. This broad negativity more closely resembles the Nd 
(negative difference) response originally reported by Hillyard and colleagues (e.g., Hansen & 
Hillyard 1980), and which may reflect separate components (e.g., Giard et al 1988). Currently 
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we are examining the broader Nd observed on this task and conducting several studies to 
differentiate increases in specific ERPs (e.g., N100, P200) versus a broad negativity (the Nd). 
 Several caveats must be discussed. The number of subjects on this task is 
relatively small, and the marginal and trend-level findings may attain significance with larger 
samples. Currently we are testing additional participants on this task to that end. The insertion of 
click trains between tones leads to a broad negativity between 300 and 800 ms as shown in 
Figure 1. It is unclear to what extent this task parameter may affect the N100 enhancement. 
Currently we are testing participants without the click trains inserted. Another potential 
limitation is that the majority of patients were on antipsychotic medication at the time of 
participation. However, no participant had a long course of treatment. We did not observe an 
effect of medication on ability to modulate N100 response with attention.  
 In summary, individuals in the first-episode schizophrenia spectrum exhibit 
impaired attentional modulation of their N100 ERP on the oddball task, indicating abnormal 
attentional processing can be objectively measured from neurophysiological sensory responses at 
the start of psychosis. This finding suggests that the impairment in selective attention is present 
at the onset of psychotic symptoms. The results of this study therefore support the use of N100 
modulation in the oddball task as a potential diagnostic tool in clinical settings. Future work will 
collect data from more subjects, further investigate the hypothesized functional disconnection 
present in diseased auditory processing, and test the effectiveness of this impairment as a 
predictor of disease presence.  
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